Abbott Laboratories (ABT) Share-based Compensation Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.94% |
| Dec 31, 2025 | 2.89% |
| Sep 30, 2025 | 3.71% |
| Jun 30, 2025 | 4.31% |
| Mar 31, 2025 | 4.40% |
| Dec 31, 2024 | 5.48% |
| Sep 30, 2024 | 4.47% |
| Jun 30, 2024 | 4.34% |
| Mar 31, 2024 | 6.11% |
| Dec 31, 2023 | 7.07% |
| Sep 30, 2023 | 7.11% |
| Jun 30, 2023 | 5.50% |
| Mar 31, 2023 | 5.80% |
| Dec 31, 2022 | 11.08% |
| Sep 30, 2022 | 10.40% |
| Jun 30, 2022 | 9.07% |
| Mar 31, 2022 | 12.27% |
| Dec 31, 2021 | 17.66% |
| Sep 30, 2021 | 18.40% |
| Jun 30, 2021 | 16.32% |
| Mar 31, 2021 | 13.63% |
| Dec 31, 2020 | 17.91% |
| Sep 30, 2020 | 18.39% |
| Jun 30, 2020 | 15.07% |
| Mar 31, 2020 | 9.50% |
| Dec 31, 2019 | 17.47% |
| Sep 30, 2019 | 18.64% |
| Jun 30, 2019 | 18.40% |
| Mar 31, 2019 | 13.69% |
| Dec 31, 2018 | 15.16% |
| Sep 30, 2018 | 13.02% |
| Jun 30, 2018 | 14.20% |
| Mar 31, 2018 | 10.97% |
| Dec 31, 2017 | -1.75% |
| Sep 30, 2017 | 8.02% |
| Jun 30, 2017 | 1.36% |
| Mar 31, 2017 | -2.82% |
| Dec 31, 2016 | -5.66% |
| Sep 30, 2016 | -6.34% |
| Jun 30, 2016 | -3.99% |
| Mar 31, 2016 | -2.87% |
| Dec 31, 2015 | -4.72% |
| Sep 30, 2015 | -10.04% |
| Jun 30, 2015 | -7.51% |
| Mar 31, 2015 | -3.17% |
| Dec 31, 2014 | -8.38% |
| Sep 30, 2014 | -8.56% |